(Q48008421)

7 February 2018

title

The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria (English)

1 reference

7 February 2018

0 references

1 reference

2

R S Nussenzweig

1 reference

7 February 2018

M Rodrigues

1

1 reference

7 February 2018

F Zavala

series ordinal

3

1 reference

7 February 2018

publication date

1 September 1993

1 reference

7 February 2018

published in

Immunology

1 reference

7 February 2018

volume

80

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

1-5

1 reference

7 February 2018

Plasmodium yoelii: quantification of the exoerythrocytic stages based on the use of ribosomal RNA probes

cites work

1 reference

12 December 2020

Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.

1 reference

12 December 2020

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

12 December 2020

The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?

1 reference

12 December 2020

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

1 reference

12 December 2020

In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide

1 reference

12 December 2020

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

1 reference

12 December 2020

The multifactorial character of the protective immunity induced by immunization with sporozoites

1 reference

12 December 2020

Specific inflammatory cell infiltration of hepatic schizonts in BALB/c mice immunized with attenuated Plasmodium yoelii sporozoites

1 reference

12 December 2020

Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria

1 reference

12 December 2020

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

1 reference

12 December 2020

Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

Synthetic peptide vaccine confers protection against murine malaria

1 reference

12 December 2020

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

12 December 2020

CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites

1 reference

12 December 2020

Rationale for the development of an engineered sporozoite malaria vaccine

1 reference

12 December 2020

Genetic control of immunity to Plasmodium yoelii sporozoites

1 reference

12 December 2020

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

1 reference

12 December 2020

In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.

1 reference

12 December 2020

CD4+ cytolytic T cell clone confers protection against murine malaria

1 reference

12 December 2020

Hepatic phase of malaria is the target of cellular mechanisms induced by the previous and the subsequent stages. A crucial role for liver nonparenchymal cells

1 reference

12 December 2020

Identifiers

1 reference

7 February 2018